Literature DB >> 15099746

Dissimilarity in the reductive unfolding pathways of two ribonuclease homologues.

Mahesh Narayan1, Guoqiang Xu, Daniel R Ripoll, Huili Zhai, Kathrin Breuker, Celestine Wanjalla, Howard J Leung, Amiel Navon, Ervin Welker, Fred W McLafferty, Harold A Scheraga.   

Abstract

Using DTT(red) as the reducing agent, the kinetics of the reductive unfolding of onconase, a frog ribonuclease, has been examined. An intermediate containing three disulfides, Ir, that is formed rapidly in the reductive pathway, is more resistant to further reduction than the parent molecule, indicating that the remaining disulfides in onconase are less accessible to DTT(red). Disulfide-bond mapping of Ir indicated that it is a single species lacking the (30-75) disulfide bond. The reductive unfolding pattern of onconase is consistent with an analysis of the exposed surface area of the cysteine sulfur atoms in the (30-75) disulfide bond, which reveals that these atoms are about four- and sevenfold, respectively, more exposed than those in the next two maximally exposed disulfides. By contrast, in the reductive unfolding of the homologue, RNase A, there are two intermediates, arising from the reduction of the (40-95) and (65-72) disulfide bonds, which takes place in parallel, and on a much longer time-scale, compared to the initial reduction of onconase; this behavior is consistent with the almost equally exposed surface areas of the cysteine sulfur atoms that form the (40-95) and (65-72) disulfide bonds in RNase A and the fourfold more exposed cysteine sulfur atoms of the (30-75) disulfide bond in onconase. Analysis and in silico mutation of the residues around the (40-95) disulfide bond in RNase A, which is analogous to the (30-75) disulfide bond of onconase, reveal that the side-chain of tyrosine 92 of RNase A, a highly conserved residue among mammalian pancreatic ribonucleases, lies atop the (40-95) disulfide bond, resulting in a shielding of the corresponding sulfur atoms from the solvent; such burial of the (30-75) sulfur atoms is absent from onconase, due to the replacement of Tyr92 by Arg73, which is situated away from the (30-75) disulfide bond and into the solvent, resulting in the large exposed surface-area of the cysteine sulfur atoms forming this bond. Removal of Tyr92 from RNase A resulted in the relatively rapid reduction of the mutant to form a single intermediate (des [40-95] Y92A), i.e. it resulted in an onconase-like reductive unfolding behavior. The reduction of the P93A mutant of RNase A proceeds through a single intermediate, the des [40-95] P93A species, as in onconase. Although mutation of Pro93 to Ala does not increase the exposed surface area of the (40-95) cysteine sulfur atoms, structural analysis of the mutant reveals that there is greater flexibility in the (40-95) disulfide bond compared to the (65-72) disulfide bond that may make the (40-95) disulfide bond much easier to expose, consistent with the reductive unfolding pathway and kinetics of P93A. Mutation of Tyr92 to Phe92 in RNase A has no effect on its reductive unfolding pathway, suggesting that the hydrogen bond between the hydroxyl group of Tyr92 and the carbonyl group of Lys37 has no impact on the local unfolding free energy required to expose the (40-95) disulfide bond. Thus, these data shed light on the differences between the reductive unfolding pathways of the two homologous proteins and provide a structural basis for the origin of this difference.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15099746     DOI: 10.1016/j.jmb.2004.03.014

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  12 in total

1.  Identification of formation of initial native structure in onconase from an unfolded state.

Authors:  Robert F Gahl; Robert E Oswald; Harold A Scheraga
Journal:  Biochemistry       Date:  2011-12-14       Impact factor: 3.162

2.  Oxidative folding and N-terminal cyclization of onconase.

Authors:  Ervin Welker; Laura Hathaway; Guoqiang Xu; Mahesh Narayan; Lovy Pradeep; Hang-Cheol Shin; Harold A Scheraga
Journal:  Biochemistry       Date:  2007-04-18       Impact factor: 3.162

3.  A localized specific interaction alters the unfolding pathways of structural homologues.

Authors:  Guoqiang Xu; Mahesh Narayan; Igor Kurinov; Daniel R Ripoll; Ervin Welker; Mey Khalili; Steven E Ealick; Harold A Scheraga
Journal:  J Am Chem Soc       Date:  2006-02-01       Impact factor: 15.419

4.  Stepwise deamidation of ribonuclease A at five sites determined by top down mass spectrometry.

Authors:  Vlad Zabrouskov; Xuemei Han; Ervin Welker; Huili Zhai; Cheng Lin; Klaas J van Wijk; Harold A Scheraga; Fred W McLafferty
Journal:  Biochemistry       Date:  2006-01-24       Impact factor: 3.162

5.  Oxidative folding of hirudin in human serum.

Authors:  Jui-Yoa Chang; Bao-Yun Lu; Por-Hsiung Lai
Journal:  Biochem J       Date:  2006-02-15       Impact factor: 3.857

6.  Simultaneous kinetic characterization of multiple protein forms by top down mass spectrometry.

Authors:  Huili Zhai; Pieter C Dorrestein; Abhishek Chatterjee; Tadhg P Begley; Fred W McLafferty
Journal:  J Am Soc Mass Spectrom       Date:  2005-07       Impact factor: 3.109

Review 7.  Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes.

Authors:  W Ardelt; K Shogen; Z Darzynkiewicz
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

Review 8.  Ribonucleases as potential modalities in anticancer therapy.

Authors:  Wojciech Ardelt; Barbara Ardelt; Zbigniew Darzynkiewicz
Journal:  Eur J Pharmacol       Date:  2009-10-14       Impact factor: 4.432

9.  Effects of tyrosine mutations on the conformational and oxidative folding of ribonuclease a: a comparative study.

Authors:  Robert F Gahl; Lovy Pradeep; Corey R Siegel; Guoqiang Xu; Harold A Scheraga
Journal:  Biochemistry       Date:  2009-05-12       Impact factor: 3.162

10.  Dissimilarity in the oxidative folding of onconase and ribonuclease A, two structural homologues.

Authors:  Robert F Gahl; Mahesh Narayan; Guoqiang Xu; Harold A Scheraga
Journal:  Protein Eng Des Sel       Date:  2008-01-31       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.